{"id":5481,"date":"2021-03-04T07:00:00","date_gmt":"2021-03-04T06:00:00","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/sista-dag-for-handel-med-bta\/"},"modified":"2021-03-04T07:00:00","modified_gmt":"2021-03-04T06:00:00","slug":"sista-dag-for-handel-med-bta","status":"publish","type":"cision-feed","link":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/sista-dag-for-handel-med-bta\/","title":{"rendered":"Sista dag f\u00f6r handel med BTA"},"content":{"rendered":"<p style=\"text-align:justify\"><span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\">Under februari 2021 genomf\u00f6rde Stayble en framg\u00e5ngsrik f\u00f6retr\u00e4desemission som tillf\u00f6rde Bolaget cirka 41,5 MSEK f\u00f6re emissionskostnader. F\u00f6retr\u00e4desemissionen har nu registrerats hos Bolagsverket och sista dag f\u00f6r handel med BTA \u00e4r den 8 mars 2021 och stoppdag \u00e4r den 10 mars 2021. Aktier ber\u00e4knas distribueras till VP-konto\/dep\u00e5 den 12 mars 2021. <\/span><\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><strong><span style=\"font-size:9pt\"><span style=\"color:#3b3838\">R\u00e5dgivare<\/span><\/span><\/strong><\/span><\/span><\/span><br \/>\n<span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\">Sedermera Fondkommission \u00e4r finansiell r\u00e5dgivare, Markets &amp; Corporate Law Nordic AB \u00e4r legal r\u00e5dgivare och Nordic Issuing agerar emissionsinstitut i samband med f\u00f6retr\u00e4desemissionen.<\/span><\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"background-color:white\"><strong><span style=\"font-size:9pt\"><span style=\"color:#3b3838\">F\u00f6r ytterligare information om f\u00f6retr\u00e4desemissionen<\/span><\/span><\/strong><\/span><\/span><br \/>\n<span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><span style=\"line-height:115%\">Sedermera Fondkommission<\/span><\/span><\/span><\/span><\/span><br \/>\n<span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><span style=\"line-height:115%\">Telefon: +46 40 615 14 10<\/span><\/span><\/span><\/span><\/span><br \/>\n<span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><span style=\"line-height:115%\">E-post: <\/span><a href=\"mailto:info@sedermera.se\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><span style=\"text-decoration:none\">info@sedermera.se<\/span><\/span><\/span><\/a><\/span><\/span><\/span><\/span><br \/>\n<span style=\"font-family:tahoma,arial,helvetica,sans-serif\"><span style=\"font-size:9pt\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><a href=\"http:\/\/www.sedermera.se\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"line-height:115%\"><span style=\"color:#3b3838\"><span style=\"text-decoration:none\">www.sedermera.se<\/span><\/span><\/span><\/a><\/span><\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stayble Therapeutics AB (\u201dStayble\u201d eller \u201dBolaget\u201d) meddelar h\u00e4rmed att sista dag f\u00f6r handel med BTA (Betald Tecknad Aktie) \u00e4r den 8 mars 2021 och stoppdag \u00e4r den 10 mars 2021.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5481"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/cision-feed"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5481"}],"version-history":[{"count":0,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5481\/revisions"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}